An improved model to predict physiologically based model parameters and their inter-individual variability from anthropometry.
about
Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies.Towards a rational design of solid drug nanoparticles with optimised pharmacological properties.Prediction of in vivo developmental toxicity of all-trans-retinoic acid based on in vitro toxicity data and in silico physiologically based kinetic modeling.Use of a physiologically-based pharmacokinetic model to simulate artemether dose adjustment for overcoming the drug-drug interaction with efavirenz.Profiling of drugs and environmental chemicals for functional impairment of neural crest migration in a novel stem cell-based test batteryPhysiologically Based Pharmacokinetic Modelling to Inform Development of Intramuscular Long-Acting Nanoformulations for HIV.Efavirenz Is Predicted To Accumulate in Brain Tissue: an In Silico, In Vitro, and In Vivo Investigation.Similarities and differences in gastrointestinal physiology between neonates and adults: a physiologically based pharmacokinetic modeling perspective.Applications of physiologically based pharmacokinetic modeling for the optimization of anti-infective therapies.Population physiologically-based pharmacokinetic model incorporating lymphatic uptake for a subcutaneously administered pegylated peptide.Identifying populations sensitive to environmental chemicals by simulating toxicokinetic variability.In Silico Dose Prediction for Long-Acting Rilpivirine and Cabotegravir Administration to Children and Adolescents.Simulating Intestinal Transporter and Enzyme Activity in a Physiologically Based Pharmacokinetic Model for Tenofovir Disoproxil Fumarate.Use of a physiologically based pharmacokinetic model to simulate drug-drug interactions between antineoplastic and antiretroviral drugs.Physiologically Based Pharmacokinetic Modeling to Predict Drug-Drug Interactions with Efavirenz Involving Simultaneous Inducing and Inhibitory Effects on Cytochromes.Antiretroviral solid drug nanoparticles with enhanced oral bioavailability: production, characterization, and in vitro-in vivo correlation.Linking physiologically-based pharmacokinetic and genome-scale metabolic networks to understand estradiol biology.Physiologically based pharmacokinetic modelling prediction of the effects of dose adjustment in drug-drug interactions between levonorgestrel contraceptive implants and efavirenz-based ART.To Apply Microdosing or Not? Recommendations to Single Out Compounds with Non-Linear Pharmacokinetics.Physiologically based pharmacokinetic models for the optimization of antiretroviral therapy: recent progress and future perspective
P2860
Q28821119-E9A66A7A-4534-451B-BF94-941DC47E8AA4Q30372133-359812F8-7FA7-4D5F-806D-7D6F18CFE388Q30831574-AFB03275-31F0-48FB-9CDF-140E02713568Q34503553-5A3E65E6-1F2C-4B97-BE1E-90B873523F86Q35137761-98B765A4-CD3B-40BE-B698-75D0682D5F6EQ35668556-EF6B48E9-2C16-41D2-8803-0FDD6192D34BQ37538717-EA2411A2-4C87-469E-9A18-F59AF264C605Q38245572-7E94E636-95A3-48A8-B729-4F0A2A4AD7D5Q38420688-E1630B7F-99CF-4550-B97F-969DF881A57AQ38705177-469BF5E3-2E1B-4574-8BCC-9337DF59935AQ38719119-0A70A59C-3D6C-44E8-A310-BC22623A4B72Q38765921-4DEBE3E6-D7E5-420D-95F6-2121A07135AEQ38833637-4A0D4F9D-FCFF-407B-A339-E6EDC6F17146Q39080596-8E08E241-E112-47E1-8AEC-56ADEAAD4365Q39418438-E0FB121C-B94F-4283-B60D-3E2A93F37113Q46448056-21F141AE-B2AF-4A27-8BFC-B201316E7369Q47114235-F6F1F17A-9C52-4800-9882-63FF61A6CD1EQ48524975-524BBCC0-AE93-494C-830D-8A0F7EF1E79CQ50871327-604CF2D3-4A7F-4291-AD81-614CC86E818AQ58073610-E1EAEF4B-18C7-4D65-91A3-39509A38F3B9
P2860
An improved model to predict physiologically based model parameters and their inter-individual variability from anthropometry.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
An improved model to predict p ...... ariability from anthropometry.
@en
type
label
An improved model to predict p ...... ariability from anthropometry.
@en
prefLabel
An improved model to predict p ...... ariability from anthropometry.
@en
P2093
P2860
P1476
An improved model to predict p ...... ariability from anthropometry.
@en
P2093
Jan van Eijkeren
Marco Zeilmaker
Sieto Bosgra
P2860
P304
P356
10.3109/10408444.2012.709225
P407
P577
2012-09-07T00:00:00Z